# Humoral Immunity Study After a Booster Dose of Soberana Plus (FINLAY-FR-1A) Vaccine Against COVID-19

> **NCT05689177** · NA · UNKNOWN · sponsor: **Gomel State Medical University** · enrollment: 100 (estimated)

## Conditions studied

- Humoral Immunity

## Interventions

- **BIOLOGICAL:** Protein subunit vaccine Soberana Plus (FINLAY-FR-1A) is a vaccine against COVID-19 produced by The Finlay Vaccine Institute and The Centre of Molecular Immunology (Republic of Cuba)

## Key facts

- **NCT ID:** NCT05689177
- **Lead sponsor:** Gomel State Medical University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-12-09
- **Primary completion:** 2023-03-10
- **Final completion:** 2023-07-28
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2023-02-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05689177

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05689177, "Humoral Immunity Study After a Booster Dose of Soberana Plus (FINLAY-FR-1A) Vaccine Against COVID-19". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT05689177. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*